메뉴 건너뛰기




Volumn 162, Issue 6, 2015, Pages 1365-1378

Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival

(28)  Johnston, Amelia J a   Murphy, Kate T b   Jenkinson, Laura a   Laine, David a   Emmrich, Kerstin a   Faou, Pierre a   Weston, Ross a   Jayatilleke, Krishnath M a   Schloegel, Jessie a   Talbo, Gert a   Casey, Joanne L a   Levina, Vita a   Wong, W Wei Lynn c   Dillon, Helen a   Sahay, Tushar a   Hoogenraad, Joan a   Anderton, Holly a,b,d   Hall, Cathrine b,d   Schneider, Pascal e   Tanzer, Maria b,d   more..


Author keywords

[No Author keywords available]

Indexed keywords

FN14 ANTIBODY; FN14 PROTEIN; MONOCLONAL ANTIBODY; RECEPTOR; UNCLASSIFIED DRUG; TNFSF12 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TWEAK RECEPTOR;

EID: 84941342886     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.08.031     Document Type: Article
Times cited : (110)

References (41)
  • 3
    • 0038708366 scopus 로고    scopus 로고
    • The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation
    • S.A. Brown, C.M. Richards, H.N. Hanscom, S.L. Feng, and J.A. Winkles The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation Biochem. J. 371 2003 395 403
    • (2003) Biochem. J. , vol.371 , pp. 395-403
    • Brown, S.A.1    Richards, C.M.2    Hanscom, H.N.3    Feng, S.L.4    Winkles, J.A.5
  • 4
    • 33746093941 scopus 로고    scopus 로고
    • TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules
    • S.A. Brown, H.N. Hanscom, H. Vu, S.A. Brew, and J.A. Winkles TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules Biochem. J. 397 2006 297 304
    • (2006) Biochem. J. , vol.397 , pp. 297-304
    • Brown, S.A.1    Hanscom, H.N.2    Vu, H.3    Brew, S.A.4    Winkles, J.A.5
  • 5
    • 80054865852 scopus 로고    scopus 로고
    • TWEAK/Fn14 pathway: An immunological switch for shaping tissue responses
    • L.C. Burkly, J.S. Michaelson, and T.S. Zheng TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses Immunol. Rev. 244 2011 99 114
    • (2011) Immunol. Rev. , vol.244 , pp. 99-114
    • Burkly, L.C.1    Michaelson, J.S.2    Zheng, T.S.3
  • 6
    • 24644506070 scopus 로고    scopus 로고
    • The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity
    • S. Campbell, J. Michaelson, L. Burkly, and C. Putterman The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity Front. Biosci. 9 2004 2273 2284
    • (2004) Front. Biosci. , vol.9 , pp. 2273-2284
    • Campbell, S.1    Michaelson, J.2    Burkly, L.3    Putterman, C.4
  • 10
    • 34249775509 scopus 로고    scopus 로고
    • TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine
    • C. Dogra, H. Changotra, N. Wedhas, X. Qin, J.E. Wergedal, and A. Kumar TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine FASEB J. 21 2007 1857 1869
    • (2007) FASEB J. , vol.21 , pp. 1857-1869
    • Dogra, C.1    Changotra, H.2    Wedhas, N.3    Qin, X.4    Wergedal, J.E.5    Kumar, A.6
  • 11
    • 33744542153 scopus 로고    scopus 로고
    • Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein
    • C. Dogra, H. Changotra, S. Mohan, and A. Kumar Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein J. Biol. Chem. 281 2006 10327 10336
    • (2006) J. Biol. Chem. , vol.281 , pp. 10327-10336
    • Dogra, C.1    Changotra, H.2    Mohan, S.3    Kumar, A.4
  • 12
    • 0022891340 scopus 로고
    • Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
    • H.F. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N. Engl. J. Med. 315 1986 1650 1659
    • (1986) N. Engl. J. Med. , vol.315 , pp. 1650-1659
    • Dvorak, H.F.1
  • 13
    • 0019739585 scopus 로고
    • Preparation of monoclonal antibodies: Strategies and procedures
    • G. Galfrè, and C. Milstein Preparation of monoclonal antibodies: strategies and procedures Methods Enzymol. 73 Pt B 1981 3 46
    • (1981) Methods Enzymol. , vol.73 , pp. 3-46
    • Galfrè, G.1    Milstein, C.2
  • 15
    • 0038242506 scopus 로고    scopus 로고
    • TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors
    • S. Han, K. Yoon, K. Lee, K. Kim, H. Jang, N.K. Lee, K. Hwang, and S. Young Lee TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors Biochem. Biophys. Res. Commun. 305 2003 789 796
    • (2003) Biochem. Biophys. Res. Commun. , vol.305 , pp. 789-796
    • Han, S.1    Yoon, K.2    Lee, K.3    Kim, K.4    Jang, H.5    Lee, N.K.6    Hwang, K.7    Young Lee, S.8
  • 16
    • 0035875178 scopus 로고    scopus 로고
    • Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation
    • B.S. Islam-Ali, and M.J. Tisdale Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation Br. J. Cancer 84 2001 1648 1655
    • (2001) Br. J. Cancer , vol.84 , pp. 1648-1655
    • Islam-Ali, B.S.1    Tisdale, M.J.2
  • 17
    • 33750350777 scopus 로고    scopus 로고
    • Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis
    • K. Kamata, S. Kamijo, A. Nakajima, A. Koyanagi, H. Kurosawa, H. Yagita, and K. Okumura Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis J. Immunol. 177 2006 6433 6439
    • (2006) J. Immunol. , vol.177 , pp. 6433-6439
    • Kamata, K.1    Kamijo, S.2    Nakajima, A.3    Koyanagi, A.4    Kurosawa, H.5    Yagita, H.6    Okumura, K.7
  • 18
    • 84869856705 scopus 로고    scopus 로고
    • Current pharmacotherapy options for cancer anorexia and cachexia
    • A. Macciò, C. Madeddu, and G. Mantovani Current pharmacotherapy options for cancer anorexia and cachexia Expert Opin. Pharmacother. 13 2012 2453 2472
    • (2012) Expert Opin. Pharmacother. , vol.13 , pp. 2453-2472
    • MacCiò, A.1    Madeddu, C.2    Mantovani, G.3
  • 20
    • 77957338124 scopus 로고    scopus 로고
    • Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice
    • A. Mittal, S. Bhatnagar, A. Kumar, P.K. Paul, S. Kuang, and A. Kumar Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice Am. J. Pathol. 177 2010 1732 1742
    • (2010) Am. J. Pathol. , vol.177 , pp. 1732-1742
    • Mittal, A.1    Bhatnagar, S.2    Kumar, A.3    Paul, P.K.4    Kuang, S.5    Kumar, A.6
  • 21
    • 78649853041 scopus 로고    scopus 로고
    • Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function
    • K.T. Murphy, R. Koopman, T. Naim, B. Leger, J. Trieu, C. Ibebunjo, and G.S. Lynch Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function FASEB J. 24 2010 4433 4442
    • (2010) FASEB J. , vol.24 , pp. 4433-4442
    • Murphy, K.T.1    Koopman, R.2    Naim, T.3    Leger, B.4    Trieu, J.5    Ibebunjo, C.6    Lynch, G.S.7
  • 22
    • 71649110398 scopus 로고    scopus 로고
    • Update on emerging drugs for cancer cachexia
    • K.T. Murphy, and G.S. Lynch Update on emerging drugs for cancer cachexia Expert Opin. Emerg. Drugs 14 2009 619 632
    • (2009) Expert Opin. Emerg. Drugs , vol.14 , pp. 619-632
    • Murphy, K.T.1    Lynch, G.S.2
  • 23
    • 84863434061 scopus 로고    scopus 로고
    • Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia
    • K.T. Murphy, A. Chee, J. Trieu, T. Naim, and G.S. Lynch Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia Dis. Model. Mech. 5 2012 533 545
    • (2012) Dis. Model. Mech. , vol.5 , pp. 533-545
    • Murphy, K.T.1    Chee, A.2    Trieu, J.3    Naim, T.4    Lynch, G.S.5
  • 24
    • 77950340105 scopus 로고    scopus 로고
    • Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"
    • M. Muscaritoli, S.D. Anker, J. Argilés, Z. Aversa, J.M. Bauer, G. Biolo, Y. Boirie, I. Bosaeus, T. Cederholm, P. Costelli, and et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" Clin. Nutr. 29 2010 154 159
    • (2010) Clin. Nutr. , vol.29 , pp. 154-159
    • Muscaritoli, M.1    Anker, S.D.2    Argilés, J.3    Aversa, Z.4    Bauer, J.M.5    Biolo, G.6    Boirie, Y.7    Bosaeus, I.8    Cederholm, T.9    Costelli, P.10
  • 25
    • 0037223197 scopus 로고    scopus 로고
    • Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death
    • M. Nakayama, K. Ishidoh, Y. Kojima, N. Harada, E. Kominami, K. Okumura, and H. Yagita Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death J. Immunol. 170 2003 341 348
    • (2003) J. Immunol. , vol.170 , pp. 341-348
    • Nakayama, M.1    Ishidoh, K.2    Kojima, Y.3    Harada, N.4    Kominami, E.5    Okumura, K.6    Yagita, H.7
  • 26
    • 16244391419 scopus 로고    scopus 로고
    • The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia
    • S.T. Russell, and M.J. Tisdale The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia Br. J. Cancer 92 2005 876 881
    • (2005) Br. J. Cancer , vol.92 , pp. 876-881
    • Russell, S.T.1    Tisdale, M.J.2
  • 27
    • 84877697920 scopus 로고    scopus 로고
    • Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity
    • S. Salzmann, A. Seher, J. Trebing, D. Weisenberger, A. Rosenthal, D. Siegmund, and H. Wajant Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity J. Biol. Chem. 288 2013 13455 13466
    • (2013) J. Biol. Chem. , vol.288 , pp. 13455-13466
    • Salzmann, S.1    Seher, A.2    Trebing, J.3    Weisenberger, D.4    Rosenthal, A.5    Siegmund, D.6    Wajant, H.7
  • 29
    • 84899062776 scopus 로고    scopus 로고
    • The TWEAK-Fn14 pathway: A potent regulator of skeletal muscle biology in health and disease
    • M.M. Tajrishi, T.S. Zheng, L.C. Burkly, and A. Kumar The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease Cytokine Growth Factor Rev. 25 2014 215 225
    • (2014) Cytokine Growth Factor Rev. , vol.25 , pp. 215-225
    • Tajrishi, M.M.1    Zheng, T.S.2    Burkly, L.C.3    Kumar, A.4
  • 30
    • 67649982995 scopus 로고    scopus 로고
    • Mechanisms of cancer cachexia
    • M.J. Tisdale Mechanisms of cancer cachexia Physiol. Rev. 89 2009 381 410
    • (2009) Physiol. Rev. , vol.89 , pp. 381-410
    • Tisdale, M.J.1
  • 32
    • 84858627919 scopus 로고    scopus 로고
    • Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors
    • E. Varfolomeev, T. Goncharov, H. Maecker, K. Zobel, L.G. Kömüves, K. Deshayes, and D. Vucic Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors Sci. Signal. 5 2012 ra22
    • (2012) Sci. Signal. , vol.5 , pp. ra22
    • Varfolomeev, E.1    Goncharov, T.2    Maecker, H.3    Zobel, K.4    Kömüves, L.G.5    Deshayes, K.6    Vucic, D.7
  • 33
    • 33749621818 scopus 로고    scopus 로고
    • TWEAK shall inherit the earth
    • J.E. Vince, and J. Silke TWEAK shall inherit the earth Cell Death Differ. 13 2006 1842 1844
    • (2006) Cell Death Differ. , vol.13 , pp. 1842-1844
    • Vince, J.E.1    Silke, J.2
  • 36
    • 84879155722 scopus 로고    scopus 로고
    • Diagnostic criteria of cancer cachexia: Relation to quality of life, exercise capacity and survival in unselected palliative care patients
    • O. Wallengren, K. Lundholm, and I. Bosaeus Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients Support. Care Cancer 21 2013 1569 1577
    • (2013) Support. Care Cancer , vol.21 , pp. 1569-1577
    • Wallengren, O.1    Lundholm, K.2    Bosaeus, I.3
  • 37
    • 0034032155 scopus 로고    scopus 로고
    • The symptoms of advanced cancer: Relationship to age, gender, and performance status in 1,000 patients
    • D. Walsh, S. Donnelly, and L. Rybicki The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients Support. Care Cancer 8 2000 175 179
    • (2000) Support. Care Cancer , vol.8 , pp. 175-179
    • Walsh, D.1    Donnelly, S.2    Rybicki, L.3
  • 38
    • 0000654568 scopus 로고
    • The immediate cause of death in cancer
    • S. Warren The immediate cause of death in cancer Am. J. Med. Sci. 184 1932 610 613
    • (1932) Am. J. Med. Sci. , vol.184 , pp. 610-613
    • Warren, S.1
  • 40
    • 42949160019 scopus 로고    scopus 로고
    • The TWEAK-Fn14 cytokine-receptor axis: Discovery, biology and therapeutic targeting
    • J.A. Winkles The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting Nat. Rev. Drug Discov. 7 2008 411 425
    • (2008) Nat. Rev. Drug Discov. , vol.7 , pp. 411-425
    • Winkles, J.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.